 Christopher Baker
Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchopulmonary Dysplasia | 21 | 2023 | 325 | 6.020 |
Why?
| | Tracheostomy | 14 | 2023 | 102 | 5.360 |
Why?
| | Respiration, Artificial | 14 | 2023 | 543 | 3.790 |
Why?
| | Infant, Premature | 16 | 2023 | 479 | 1.940 |
Why?
| | Respiratory Insufficiency | 4 | 2021 | 289 | 1.670 |
Why?
| | Ventilator Weaning | 3 | 2016 | 33 | 1.650 |
Why?
| | Home Care Services | 4 | 2022 | 215 | 1.430 |
Why?
| | Ventilators, Mechanical | 6 | 2023 | 46 | 1.220 |
Why?
| | Infant, Newborn | 25 | 2023 | 5230 | 1.180 |
Why?
| | Infant, Premature, Diseases | 2 | 2021 | 91 | 1.150 |
Why?
| | Continuity of Patient Care | 3 | 2017 | 262 | 1.100 |
Why?
| | Fetal Blood | 5 | 2016 | 270 | 1.070 |
Why?
| | Tracheobronchomalacia | 2 | 2022 | 14 | 1.030 |
Why?
| | Respiratory Tract Diseases | 2 | 2022 | 142 | 0.930 |
Why?
| | Infant | 19 | 2023 | 8254 | 0.900 |
Why?
| | Stem Cells | 3 | 2013 | 556 | 0.880 |
Why?
| | Premature Birth | 4 | 2023 | 284 | 0.870 |
Why?
| | Tracheomalacia | 1 | 2022 | 19 | 0.850 |
Why?
| | Tracheoesophageal Fistula | 1 | 2022 | 33 | 0.840 |
Why?
| | Patient Care Team | 3 | 2016 | 521 | 0.830 |
Why?
| | Device Removal | 3 | 2019 | 127 | 0.800 |
Why?
| | Trachea | 1 | 2023 | 225 | 0.800 |
Why?
| | Airway Extubation | 2 | 2019 | 45 | 0.800 |
Why?
| | Infant, Extremely Premature | 3 | 2021 | 57 | 0.780 |
Why?
| | Feeding and Eating Disorders | 1 | 2022 | 125 | 0.760 |
Why?
| | Deglutition Disorders | 1 | 2022 | 128 | 0.760 |
Why?
| | Child | 25 | 2023 | 19033 | 0.760 |
Why?
| | Cutaneous Fistula | 1 | 2019 | 13 | 0.700 |
Why?
| | Respiratory Tract Fistula | 1 | 2019 | 8 | 0.700 |
Why?
| | Patient Discharge | 5 | 2022 | 791 | 0.700 |
Why?
| | Tracheal Diseases | 1 | 2019 | 16 | 0.700 |
Why?
| | Lung | 6 | 2023 | 3623 | 0.690 |
Why?
| | Endothelial Cells | 4 | 2013 | 717 | 0.680 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2019 | 100 | 0.650 |
Why?
| | Humans | 51 | 2023 | 118268 | 0.610 |
Why?
| | Curriculum | 3 | 2021 | 908 | 0.590 |
Why?
| | Pamphlets | 1 | 2016 | 24 | 0.580 |
Why?
| | Animals, Newborn | 3 | 2015 | 804 | 0.580 |
Why?
| | Pulmonary Alveoli | 3 | 2018 | 375 | 0.580 |
Why?
| | Hypertension, Pulmonary | 5 | 2018 | 1784 | 0.580 |
Why?
| | Endothelial Progenitor Cells | 1 | 2016 | 19 | 0.580 |
Why?
| | Simulation Training | 1 | 2017 | 66 | 0.560 |
Why?
| | Pulmonary Diffusing Capacity | 1 | 2016 | 58 | 0.560 |
Why?
| | Pulmonary Gas Exchange | 1 | 2016 | 117 | 0.550 |
Why?
| | Airway Obstruction | 2 | 2021 | 167 | 0.550 |
Why?
| | Lung Diseases | 1 | 2021 | 709 | 0.510 |
Why?
| | Clinical Protocols | 1 | 2016 | 234 | 0.500 |
Why?
| | Hyperoxia | 3 | 2013 | 97 | 0.500 |
Why?
| | Neovascularization, Physiologic | 2 | 2013 | 181 | 0.500 |
Why?
| | Human Umbilical Vein Endothelial Cells | 2 | 2022 | 94 | 0.490 |
Why?
| | Pre-Eclampsia | 1 | 2016 | 183 | 0.480 |
Why?
| | Self Care | 1 | 2016 | 356 | 0.480 |
Why?
| | Central Nervous System Diseases | 1 | 2014 | 64 | 0.470 |
Why?
| | Organogenesis | 1 | 2014 | 54 | 0.470 |
Why?
| | Anti-Bacterial Agents | 1 | 2023 | 1514 | 0.470 |
Why?
| | Neovascularization, Pathologic | 1 | 2015 | 286 | 0.460 |
Why?
| | Culture Media, Conditioned | 1 | 2013 | 108 | 0.450 |
Why?
| | Bronchitis, Chronic | 1 | 2012 | 20 | 0.440 |
Why?
| | Quality Improvement | 2 | 2017 | 962 | 0.440 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2013 | 39 | 0.440 |
Why?
| | Regeneration | 1 | 2014 | 166 | 0.430 |
Why?
| | Umbilical Cord | 1 | 2013 | 84 | 0.430 |
Why?
| | Caregivers | 2 | 2017 | 709 | 0.410 |
Why?
| | Patient Education as Topic | 1 | 2016 | 696 | 0.410 |
Why?
| | Bleomycin | 1 | 2013 | 228 | 0.410 |
Why?
| | Developmental Disabilities | 1 | 2014 | 245 | 0.400 |
Why?
| | Interleukin-8 | 1 | 2012 | 240 | 0.400 |
Why?
| | Molecular Targeted Therapy | 1 | 2014 | 355 | 0.400 |
Why?
| | Length of Stay | 1 | 2016 | 1027 | 0.390 |
Why?
| | Child, Preschool | 9 | 2023 | 9448 | 0.390 |
Why?
| | Sputum | 1 | 2012 | 291 | 0.380 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2013 | 189 | 0.380 |
Why?
| | Communication | 1 | 2016 | 754 | 0.370 |
Why?
| | Hospital Mortality | 1 | 2014 | 811 | 0.360 |
Why?
| | Acute Lung Injury | 1 | 2013 | 278 | 0.350 |
Why?
| | Positive-Pressure Respiration | 3 | 2023 | 70 | 0.350 |
Why?
| | Algorithms | 1 | 2016 | 1522 | 0.330 |
Why?
| | Postoperative Complications | 1 | 2019 | 2230 | 0.320 |
Why?
| | Argyria | 1 | 2007 | 4 | 0.320 |
Why?
| | Silver | 1 | 2007 | 27 | 0.310 |
Why?
| | Female | 18 | 2023 | 61268 | 0.310 |
Why?
| | Skin Pigmentation | 1 | 2007 | 43 | 0.310 |
Why?
| | Neutrophils | 1 | 2012 | 1142 | 0.300 |
Why?
| | Morbidity | 3 | 2022 | 293 | 0.280 |
Why?
| | Chronic Disease | 3 | 2021 | 1631 | 0.270 |
Why?
| | Male | 14 | 2019 | 57479 | 0.250 |
Why?
| | Pregnancy | 5 | 2021 | 5671 | 0.250 |
Why?
| | Cells, Cultured | 4 | 2016 | 4044 | 0.220 |
Why?
| | von Willebrand Diseases | 1 | 2022 | 13 | 0.210 |
Why?
| | von Willebrand Factor | 1 | 2022 | 57 | 0.210 |
Why?
| | Insufflation | 1 | 2021 | 9 | 0.200 |
Why?
| | Spinal Muscular Atrophies of Childhood | 1 | 2021 | 15 | 0.200 |
Why?
| | Pulmonary Ventilation | 1 | 2021 | 71 | 0.190 |
Why?
| | Flow Cytometry | 2 | 2016 | 1072 | 0.190 |
Why?
| | Retrospective Studies | 6 | 2023 | 12932 | 0.180 |
Why?
| | Steroids | 2 | 2022 | 153 | 0.180 |
Why?
| | Aftercare | 1 | 2021 | 194 | 0.180 |
Why?
| | Leukocytes, Mononuclear | 2 | 2013 | 504 | 0.180 |
Why?
| | Emergencies | 1 | 2020 | 152 | 0.180 |
Why?
| | Tracheotomy | 1 | 2019 | 21 | 0.180 |
Why?
| | Polysomnography | 1 | 2019 | 156 | 0.170 |
Why?
| | Ambulatory Care | 1 | 2022 | 481 | 0.160 |
Why?
| | Glycogen Storage Disease | 1 | 2018 | 21 | 0.160 |
Why?
| | Cystic Fibrosis | 1 | 2007 | 963 | 0.160 |
Why?
| | Dental Cements | 1 | 2017 | 21 | 0.160 |
Why?
| | Adolescent | 4 | 2022 | 18364 | 0.160 |
Why?
| | Young Adult | 3 | 2019 | 10731 | 0.160 |
Why?
| | Pediatrics | 3 | 2021 | 980 | 0.150 |
Why?
| | Long-Term Care | 1 | 2017 | 74 | 0.150 |
Why?
| | Transitional Care | 1 | 2017 | 38 | 0.150 |
Why?
| | Cell Proliferation | 3 | 2013 | 2262 | 0.150 |
Why?
| | Oxygen Inhalation Therapy | 2 | 2015 | 124 | 0.150 |
Why?
| | Reproducibility of Results | 2 | 2023 | 2856 | 0.140 |
Why?
| | Infant Care | 1 | 2016 | 43 | 0.140 |
Why?
| | Expectorants | 1 | 2016 | 24 | 0.140 |
Why?
| | Interrupted Time Series Analysis | 1 | 2016 | 45 | 0.140 |
Why?
| | Tidal Volume | 1 | 2016 | 74 | 0.140 |
Why?
| | Computer Simulation | 1 | 2020 | 913 | 0.140 |
Why?
| | Hospitals, Pediatric | 1 | 2019 | 504 | 0.130 |
Why?
| | Rats | 2 | 2015 | 5339 | 0.130 |
Why?
| | Pulmonary Medicine | 1 | 2016 | 85 | 0.130 |
Why?
| | Adrenal Cortex Hormones | 2 | 2018 | 517 | 0.130 |
Why?
| | Echocardiography | 1 | 2017 | 556 | 0.130 |
Why?
| | Diuretics | 1 | 2015 | 76 | 0.130 |
Why?
| | Adrenergic beta-Agonists | 1 | 2015 | 130 | 0.120 |
Why?
| | Carbon Dioxide | 1 | 2016 | 230 | 0.120 |
Why?
| | Risk Factors | 3 | 2019 | 8958 | 0.120 |
Why?
| | Monitoring, Physiologic | 1 | 2016 | 268 | 0.120 |
Why?
| | Lung Diseases, Interstitial | 1 | 2018 | 464 | 0.110 |
Why?
| | Hernia, Diaphragmatic | 1 | 2013 | 68 | 0.110 |
Why?
| | Immunoenzyme Techniques | 1 | 2013 | 195 | 0.110 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2013 | 114 | 0.110 |
Why?
| | Leukocyte Count | 1 | 2013 | 303 | 0.110 |
Why?
| | Survival Rate | 1 | 2016 | 1716 | 0.100 |
Why?
| | Colorado | 2 | 2019 | 4178 | 0.100 |
Why?
| | Vascular Diseases | 1 | 2015 | 241 | 0.100 |
Why?
| | Time Factors | 2 | 2019 | 6368 | 0.100 |
Why?
| | Internship and Residency | 1 | 2021 | 1005 | 0.100 |
Why?
| | Survival Analysis | 1 | 2014 | 1262 | 0.100 |
Why?
| | Maternal Exposure | 1 | 2012 | 140 | 0.090 |
Why?
| | Blotting, Western | 1 | 2013 | 1186 | 0.090 |
Why?
| | United States | 4 | 2022 | 12496 | 0.090 |
Why?
| | Treatment Outcome | 2 | 2016 | 9319 | 0.090 |
Why?
| | Risk | 1 | 2012 | 849 | 0.090 |
Why?
| | Outpatients | 2 | 2023 | 324 | 0.080 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 1130 | 0.080 |
Why?
| | Follow-Up Studies | 1 | 2017 | 4575 | 0.080 |
Why?
| | Risk Assessment | 1 | 2017 | 3043 | 0.080 |
Why?
| | Animals | 3 | 2015 | 33152 | 0.080 |
Why?
| | Rats, Sprague-Dawley | 1 | 2013 | 2434 | 0.080 |
Why?
| | Colloids | 1 | 2007 | 59 | 0.080 |
Why?
| | Biomarkers | 1 | 2017 | 3568 | 0.080 |
Why?
| | Pulmonary Artery | 1 | 2013 | 1055 | 0.070 |
Why?
| | Complementary Therapies | 1 | 2007 | 71 | 0.070 |
Why?
| | Gestational Age | 2 | 2021 | 765 | 0.070 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2009 | 523 | 0.070 |
Why?
| | Disease Models, Animal | 1 | 2015 | 3676 | 0.070 |
Why?
| | Antioxidants | 1 | 2009 | 564 | 0.070 |
Why?
| | Adult | 2 | 2016 | 31327 | 0.060 |
Why?
| | Nitric Oxide | 1 | 2009 | 891 | 0.060 |
Why?
| | Weibel-Palade Bodies | 1 | 2022 | 3 | 0.050 |
Why?
| | Child Day Care Centers | 1 | 2022 | 34 | 0.050 |
Why?
| | Prevalence | 2 | 2021 | 2321 | 0.050 |
Why?
| | Lung Volume Measurements | 1 | 2021 | 46 | 0.050 |
Why?
| | Tomography | 1 | 2021 | 23 | 0.050 |
Why?
| | Electric Impedance | 1 | 2021 | 99 | 0.050 |
Why?
| | Insurance Coverage | 1 | 2022 | 208 | 0.050 |
Why?
| | Single-Cell Analysis | 1 | 2022 | 186 | 0.050 |
Why?
| | RNA, Small Interfering | 1 | 2022 | 562 | 0.040 |
Why?
| | Mice | 1 | 2015 | 15446 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2021 | 746 | 0.040 |
Why?
| | Prospective Studies | 2 | 2023 | 6443 | 0.040 |
Why?
| | Principal Component Analysis | 1 | 2017 | 179 | 0.040 |
Why?
| | Pilot Projects | 1 | 2021 | 1405 | 0.040 |
Why?
| | Education, Medical, Graduate | 1 | 2021 | 399 | 0.040 |
Why?
| | Societies | 1 | 2016 | 42 | 0.030 |
Why?
| | Respiration | 1 | 2016 | 184 | 0.030 |
Why?
| | Indiana | 1 | 2015 | 29 | 0.030 |
Why?
| | Education, Medical, Continuing | 1 | 2016 | 124 | 0.030 |
Why?
| | Fundoplication | 1 | 2015 | 56 | 0.030 |
Why?
| | Biopsy | 1 | 2018 | 1078 | 0.030 |
Why?
| | Gastrostomy | 1 | 2015 | 93 | 0.030 |
Why?
| | Infant, Low Birth Weight | 1 | 2015 | 125 | 0.030 |
Why?
| | Clinical Competence | 1 | 2021 | 950 | 0.030 |
Why?
| | Schools, Medical | 1 | 2015 | 138 | 0.030 |
Why?
| | Administration, Inhalation | 1 | 2015 | 652 | 0.030 |
Why?
| | Software | 1 | 2017 | 566 | 0.030 |
Why?
| | Heart Defects, Congenital | 1 | 2018 | 700 | 0.030 |
Why?
| | Surveys and Questionnaires | 1 | 2023 | 4684 | 0.020 |
Why?
| | Disease Management | 1 | 2015 | 566 | 0.020 |
Why?
| | Ultrasonography | 1 | 2015 | 714 | 0.020 |
Why?
| | Genome-Wide Association Study | 1 | 2017 | 1318 | 0.020 |
Why?
| | Phenotype | 1 | 2018 | 2937 | 0.020 |
Why?
| | Colony-Forming Units Assay | 1 | 2009 | 94 | 0.020 |
Why?
| | Logistic Models | 1 | 2015 | 1896 | 0.020 |
Why?
| | Cell Shape | 1 | 2009 | 57 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2009 | 86 | 0.020 |
Why?
| | Air | 1 | 2009 | 48 | 0.020 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2009 | 198 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2018 | 2433 | 0.020 |
Why?
| | Incidence | 1 | 2015 | 2413 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2015 | 2659 | 0.020 |
Why?
| | Signal Transduction | 1 | 2009 | 4688 | 0.010 |
Why?
|
|
Baker's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|